NorthShore has embarked on the next major step in advancing our understanding of how comprehensive genomic information relates to improved, more personalized healthcare. Launched in March 2014, the Genomic Health Initiative (GHI) is a cutting-edge research project that allows members of our community to help shape the future of personalized medicine.
This research project gives our physician and research experts the opportunity to more proactively learn about the many variations in DNA that may be behind common diseases and conditions such as diabetes, high blood pressure, breast cancer, asthma and obesity. Our ultimate goal is to apply the knowledge gained directly to a clinical setting to improve patient outcomes.
NorthShore aims to collect tens of thousands of blood samples from patients interested in supporting our groundbreaking research efforts. In its first year alone, the GHI enrolled more than 6,000 subjects in this exciting study and continues to make it easier for members of the NorthShore community to participate. For example, we are adding multilingual capabilities such as Spanish-speaking study enrollers and phlebotomists to broaden the sample diversity—racial, ethnic—of our NorthShore service area.
The genomic study of GHI samples has already begun, allowing for the characterization of a variety of genetic variations and providing a rich resource for NorthShore investigators involved in genomic research.
It’s easy to participate!
By participating in this initiative—which involves a simple blood draw at any of NorthShore's hospital outpatient labs or patient service centers—you can help our physicians and researchers more precisely predict, prevent and treat disease while improving the future of health in our community and the medical field for generations to come.
For further questions about this initiative read our frequently asked questions or call us at 224.364.7470.